P3 Health Partners Inc (PIII)
0.6069
+0.01
(+1.13%)
USD |
NASDAQ |
May 17, 16:00
0.6069
0.00 (0.00%)
After-Hours: 20:00
P3 Health Partners Cash from Investing (TTM): -1.363M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.363M |
| December 31, 2023 | -1.827M |
| September 30, 2023 | -1.989M |
| June 30, 2023 | -7.984M |
| March 31, 2023 | -7.048M |
| Date | Value |
|---|---|
| December 31, 2022 | -7.733M |
| September 30, 2022 | -13.93M |
| June 30, 2022 | -8.556M |
| March 31, 2022 | -9.033M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-13.93M
Minimum
Sep 2022
-1.363M
Maximum
Mar 2024
-6.607M
Average
-7.733M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| American Shared Hospital Services | -6.273M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -122.53M |
| Cryo-Cell International Inc | -7.284M |
| Biote Corp | -14.51M |